tiprankstipranks
Trending News
More News >
Novonesis (NVZMY)
OTHER OTC:NVZMY
US Market
Advertisement

Novonesis (NVZMY) Technical Analysis

Compare
73 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
5Neutral
4Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Novonesis’s (NVZMY) Moving Averages Convergence Divergence (MACD) indicator is 0.29, suggesting Novonesis is a Sell.
Novonesis’s (NVZMY) 20-Day exponential moving average is 62.74, while Novonesis’s (NVZMY) share price is $63.44, making it a Buy.
Novonesis’s (NVZMY) 50-Day exponential moving average is 63.28, while Novonesis’s (NVZMY) share price is $63.44, making it a Buy.

Novonesis (NVZMY) Pivot Points

Oct 25, 2025, 11:45 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
63.49
63.49
63.49
63.49
63.49
63.49
63.49
Fibonacci
63.49
63.49
63.49
63.49
63.49
63.49
63.49
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Novonesis (NVZMY) Moving Averages

Oct 25, 2025, 11:45 AM
Period
Simple
Exponential
MA5
63.69Sell
63.42Buy
MA10
63.00Buy
63.12Buy
MA20
62.26Buy
62.74Buy
MA50
62.65Buy
63.28Buy
MA100
66.43Sell
64.08Sell
MA200
63.34Buy
62.40Buy
Novonesis’s (NVZMY) 10-Day exponential moving average is 63.12, while Novonesis’s (NVZMY) share price is $63.44, making it a Buy.
Novonesis’s (NVZMY) 100-Day exponential moving average is 64.08, while Novonesis’s (NVZMY) share price is $63.44, making it a Sell.
Novonesis’s (NVZMY) stock price is $63.44 and Novonesis’s (NVZMY) 50-day simple moving average is 62.65, creating a Buy signal.
Novonesis’s (NVZMY) stock price is $63.44 and Novonesis’s (NVZMY) 100-day simple moving average is 66.43, creating a Sell signal.
Novonesis’s (NVZMY) stock price is $63.44 and Novonesis’s (NVZMY) 200-day simple moving average is 63.34, creating a Buy signal.

Novonesis (NVZMY) Technical Indicators

Oct 25, 2025, 11:45 AM
Name
Value
Implied Action
RSI (14)
53.93
Neutral
STOCH (9,6)
68.21
Neutral
STOCHRSI (14)
73.71
Neutral
MACD (12,26)
0.29
Sell
ADX (14)
12.73
Buy
Williams %R
-24.62
Buy
CCI (14)
70.17
Neutral
ATR (14)
0.70
-
Ultimate Oscillator
61.77
Neutral
ROC
3.17
Buy
Novonesis’s (NVZMY) Relative Strength Index (RSI) is 53.93, creating a Neutral signal.
Novonesis’s (NVZMY) Trend Strength Indicator (ADX) is 12.73, creating a Buy signal.
Novonesis’s (NVZMY) Commodity Channel Index (CCI) is 70.17, creating a Neutral signal.
Novonesis’s (NVZMY) Price Rate of Change (ROC) is 3.17, creating a Buy signal.

FAQ

Is NVZMY a Buy, Hold, or Sell?
Based on NVZMY’s technical indicators, NVZMY is a Buy.
    What is NVZMY’s RSI (14)?
    NVZMY’s RSI (14) is 53.93, which suggests NVZMY is a Neutral.
      What is NVZMY’s MACD?
      NVZMY’s MACD is 0.29, which suggests NVZMY is a Sell.
        What is NVZMY’s 5-day moving average?
        NVZMY’s 5-day moving average is 63.69, which suggests NVZMY is a Sell.
          What is NVZMY’s 20-day moving average?
          NVZMY 20-day moving average is 62.26, which suggests NVZMY is a Buy.
            What is NVZMY’s 50-day moving average?
            NVZMY’s 50-day moving average is 62.65, which suggests NVZMY is a Buy.
              What is NVZMY’s 200-day moving average?
              NVZMY’s 200-day moving average is 63.34, which suggests NVZMY is a Buy.
                What is NVZMY’s Williams % R (14)?
                NVZMY’s Williams % R (14) is -24.62, which suggests NVZMY is a Buy.
                  What is NVZMY’s CCI (14)?
                  NVZMY’s CCI (14) is 70.17, which suggests NVZMY is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis